The most clinically significant difference is their approved use: Foundayo is approved for chronic weight management, while Ozempic is approved for Type 2 diabetes and cardiovascular risk reduction in certain patients. Both medications can help people lose weight, but that does not make them interchangeable.
“I would use Ozempic when I want a well-established option for patients with diabetes with strong A1C data. I would consider Foundayo in obesity management if access and cost make it easier, or if the patient prefers that specific oral option and it’s clinically appropriate,” says Paunel Vukasinov, MD, dual board-certified Internist and obesity medicine specialist with Medical Offices of Manhattan and contributor to Labfinder.com. Read the full article.
Would you like to book an appointment with Dr. Vukasinov?
